Standard 4: Determining Adequate Sample Sizes
暂无分享,去创建一个
J. H. van der Lee | B. Vandermeer | R. Fernandes | D. Altman | S. Ellenberg | I. van der Tweel | L. Askie | M. Offringa | D. Bassler | H. Saloojee
[1] T. Friede,et al. Re-calculating the sample size in internal pilot study designs with control of the type I error rate. , 2000, Statistics in medicine.
[2] Steven N Goodman,et al. A Bayesian approach to randomized controlled trials in children utilizing information from adults: the case of Guillain-Barre , 2005, Clinical trials.
[3] Y. Gupta,et al. Anti‐emetic effect of ginger powder versus placebo as an add‐on therapy in children and young adults receiving high emetogenic chemotherapy , 2011, Pediatric blood & cancer.
[4] J. Haybittle,et al. Repeated assessment of results in clinical trials of cancer treatment. , 1971, The British journal of radiology.
[5] B. Freidlin,et al. Release of data from an ongoing randomized clinical trial for sample size adjustment or planning , 2007, Statistics in medicine.
[6] Michael A Proschan,et al. Practical midcourse sample size modification in clinical trials. , 2003, Controlled clinical trials.
[7] A. Gould,et al. Sample size re-estimation without unblinding for normally distributed outcomes with unknown variance , 1992 .
[8] Sally Hopewell,et al. Clinical trials should begin and end with systematic reviews of relevant evidence: 12 years and waiting , 2010, The Lancet.
[9] C. H. Evans,et al. Small Clinical Trials: Issues and Challenges , 2001 .
[10] Stephen Senn,et al. Cross-over trials in clinical research , 1993 .
[11] M. Pike,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.
[12] Gordon Graham,et al. Bayesian sample size for exploratory clinical trials incorporating historical data , 2008, Statistics in medicine.
[13] Bjorn Winkens,et al. Optimal number of repeated measures and group sizes in clinical trials with linearly divergent treatment effects. , 2006, Contemporary clinical trials.
[14] D. Schoenfeld,et al. Bayesian design using adult data to augment pediatric trials , 2009, Clinical trials.
[15] Jacob Cohen,et al. A power primer. , 1992, Psychological bulletin.
[16] S. Julious. Sample sizes for clinical trials with Normal data , 2004, Statistics in medicine.
[17] J. H. van der Lee,et al. Pitfalls in the design and analysis of paediatric clinical trials: a case of a ‘failed’ multi-centre study, and potential solutions , 2008, Acta paediatrica.
[18] R. Owen,et al. Sample size calculations for clinical studies allowing for uncertainty about the variance , 2006, Pharmaceutical statistics.
[19] P. Armitage,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. , 1976, British Journal of Cancer.
[20] D L DeMets,et al. Interim analysis: the alpha spending function approach. , 1994, Statistics in medicine.
[21] W. Brannath,et al. The advantages and disadvantages of adaptive designs for clinical trials. , 2004, Drug discovery today.
[22] Guosheng Yin,et al. Fundamentals of Clinical Trials , 2012 .
[23] K. Hesketh,et al. The Early Prevention of Obesity in CHildren (EPOCH) Collaboration - an Individual Patient Data Prospective Meta-Analysis , 2010, BMC public health.
[24] Philippe Ravaud,et al. Reporting of sample size calculation in randomised controlled trials: review , 2009, BMJ : British Medical Journal.
[25] R. Ehrenkranz. Caffeine Therapy for Apnea of Prematurity , 2007 .
[27] P. Bauer,et al. Evaluation of experiments with adaptive interim analyses. , 1994, Biometrics.
[28] C D Naylor,et al. Meta-analysis of controlled clinical trials. , 1989, The Journal of rheumatology.
[29] David J Henderson-Smart,et al. Methylxanthine treatment for apnoea in preterm infants. , 2010, The Cochrane database of systematic reviews.
[30] L. Freedman. Tables of the number of patients required in clinical trials using the logrank test. , 1982, Statistics in medicine.
[31] P. O'Brien,et al. A multiple testing procedure for clinical trials. , 1979, Biometrics.
[32] Nicola J Cooper,et al. Evidence‐based sample size calculations based upon updated meta‐analysis , 2007, Statistics in medicine.
[33] J. Higgins. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .
[34] D. Henderson-smart,et al. Methylxanthine treatment for apnea in preterm infants. , 2008, The Cochrane database of systematic reviews.
[35] Arne Ohlsson,et al. Long-term effects of caffeine therapy for apnea of prematurity. , 2007, The New England journal of medicine.
[36] A Donner,et al. Approaches to sample size estimation in the design of clinical trials--a review. , 1984, Statistics in medicine.
[37] S. Stanojevic,et al. Reference values for lung function: past, present and future , 2010, European Respiratory Journal.
[38] Andrew J Vickers,et al. Underpowering in randomized trials reporting a sample size calculation. , 2003, Journal of clinical epidemiology.
[39] J. Lachin. Introduction to sample size determination and power analysis for clinical trials. , 1981, Controlled clinical trials.
[40] J. Berlin,et al. Prospective Meta‐Analysis , 2008 .
[41] J. Wittes,et al. The role of internal pilot studies in increasing the efficiency of clinical trials. , 1990, Statistics in medicine.
[42] Methods for one‐sided testing of the difference between proportions and sample size considerations related to non‐inferiority clinical trials , 2008, Pharmaceutical statistics.